Evidence map›Paper›PMID 40067560›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Socioeconomic disparities in health-related quality of life and healthcare use in the last year of life of patients with advanced cancer: longitudinal results from the eQuiPe study.

M A J Versluis, Y M van der Linden, S Oerlemans, D W Sommeijer, W K de Jong, A Baars, T J Smilde, A van der Padt-Pruijsten, L V van de Poll-Franse, N J H Raijmakers

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M A J VersluisGraduate School of Social and Behavioral Sciences, Tilburg University, PO Box 90153, 5000 LE, Tilburg, The Netherlands. m.a.j.versluis@tilburguniversity.edu.
Y M van der LindenResearch and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
S OerlemansResearch and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
D W SommeijerDepartment of Internal Medicine, Flevoziekenhuis, Almere, The Netherlands.
W K de JongDepartment of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
A BaarsDepartment of Internal Medicine, Hospital Gelderse Vallei, Ede, The Netherlands.
T J SmildeDepartment of Medical Oncology, Jeroen Bosch Hospital, SHertogenbosch, The Netherlands.
A van der Padt-PruijstenDepartment of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
L V van de Poll-FranseResearch and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
N J H RaijmakersResearch and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine socioeconomic disparities in health-related quality of life (HRQoL) and healthcare use during the last year of life of patients with advanced cancer.

methodsData was used from a prospective, longitudinal, multicenter, observational study of patients with advanced cancer in forty Dutch hospitals (eQuiPe). Adult patients with stage IV cancer completed 3-monthly questionnaires until death. Socioeconomic position (SEP) was defined as estimated income on street-level. Mixed-effects regression analysis was used to identify associated factors.

resultsA total of 639 patients were included, 14% with a lower SEP, 59% medium SEP and 28% higher SEP. Patients with a lower SEP were more often lower educated (40% vs. 18%, p < 0.001) and less often reported to have a partner (61% vs. 90%, p < 0.001) than those with a higher SEP. In the last year of life, patients with lower SEP were more likely to experience disease-related financial difficulties than those with higher SEP (28% vs. 12%, p = 0.001; β 8.2, 95%CI 2.9-13.3). No significant associations were found between SEP and HRQoL, hospital admissions or emergency department admissions. Although, patients with lower SEP had more frequent (≥ 5 per month) interactions with healthcare professionals than patients with higher SEP in the last year of life (OR 1.9, 95%CI 1.0-3.5).

conclusionSome socioeconomic disparities are present during the last year of life of patients with advanced cancer. It is important for clinicians to be aware of the greater financial impact and higher healthcare utilization in patients with a lower SEP to ensure equitable end-of-life care.

Indexed as

NeoplasmsPatient Acceptance of Health CareQuality of LifeTerminal CareAdultAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleMiddle AgedNetherlandsProspective StudiesSocioeconomic Disparities in HealthSocioeconomic FactorsAdvanced cancerHealthcare useHealth equityPalliative careQuality of lifeSocioeconomic position

Identifiers

PMID40067560
PMCPMC11897117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.